BiotechTube

Linezolid

Pre-clinicalWithdrawn
0 views this week 0 watching💤 Quiet
Interest: 18/100
18
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ventilator Acquired Pneumonia

Conditions

Ventilator Acquired Pneumonia

Trial Timeline

Jul 1, 2010 → Mar 1, 2011

NCT ID
NCT01040585

About Linezolid

Linezolid is a pre-clinical stage product being developed by Pfizer for Ventilator Acquired Pneumonia. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01040585. Target conditions include Ventilator Acquired Pneumonia.

What happened to similar drugs?

2 of 4 similar drugs in Ventilator Acquired Pneumonia were approved

Approved (2) Terminated (2) Active (0)
❌Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
❌Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
✅Imipenem + ImipenemMerckApproved
✅Vancomycin + LinezolidPfizerApproved

Hype Score Breakdown

Clinical
3
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (6)

NCT IDPhaseStatus
NCT01805284ApprovedCompleted
NCT01040585Pre-clinicalWithdrawn
NCT00255996Phase 1Completed
NCT01564758Pre-clinicalCompleted
NCT00147511ApprovedCompleted
NCT00150332Phase 3Completed

Competing Products

9 competing products in Ventilator Acquired Pneumonia

See all competitors
ProductCompanyStageHype Score
Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
32
Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + DoripenemJohnson & JohnsonPhase 2
35
Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
32
Imipenem + ImipenemMerckApproved
43
Vancomycin + LinezolidPfizerApproved
43
anidulafunginPfizerPhase 2
27
aerosolized vancomycin or gentamicinNektar TherapeuticsPhase 2
29
IC43 + PlaceboValneva SEPhase 2
29
CeftobiproleBasilea PharmaceuticaPhase 1
15